The Life Sciences Virtual Investor Forum, a B2i Digital Featured Conference co-hosted by Virtual Investor Conferences and Zacks Small-Cap Research, will take place June 24 and 25, 2026. The event provides investors with direct access to management teams from more than 20 public life sciences companies through live presentations, real-time Q&A, and one-on-one meetings.
B2i Digital, Inc. serves as the Official Marketing Partner, leveraging its distribution and media engine to drive qualified investors to the presentations. The company amplifies the event across its platform, reaching a proprietary network of more than 1.7 million retail and institutional market participants. This visibility engine has supported over 115 investor conferences, reflecting B2i Digital's integrated approach, From Marketing to Meetings℠.
Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, co-hosts the forum. Its team of life sciences analysts prepares independent company-sponsored research and related content, adding analytical depth to the presentations.
The two-day lineup spans clinical-stage biotechnology, rare-disease and oncology therapeutics, molecular diagnostics, medical devices, veterinary medicine, nutrition science, and AI-powered digital health. Each company has 30 minutes for a live presentation and Q&A. One-on-one meeting requests are available through the VIC site, and replays will be available on B2i Digital and OTC Markets YouTube channels.
“Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter, and pairing that access with independent research from Zacks makes the forum more valuable on both sides,” said David Shapiro, Chief Executive Officer of B2i Digital.
Presenting companies as of June 17 include Protalix BioTherapeutics, CytoSorbents, PetVivo Holdings, Jaguar Health, Reviva Pharmaceuticals, 4DMedical, Prostatype Genomics, Abingdon Health, Innovotech, Lakewood-Amedex Biotherapeutics, Nasus Pharma, Kelyniam Global, IMUNON, Promino Nutritional Sciences, Envoy Medical, Coiled Therapeutics, Aspire Biopharma, Rocket Doctor AI, Phio Pharmaceuticals, aTyr Pharma, and NuFarm. The full schedule and company profiles are available at the registration page.
To request one-on-one meetings with management, investors can use the Axle Access portal. The forum underscores the growing demand for efficient investor access to life sciences companies, highlighting the potential impact of emerging therapies and technologies on healthcare.
